William Eadie | September 15, 2011 4:58 PM | Cleveland, OH
Category:
FDA & Prescription Drugs
The popular diabetes drug Actos® (pioglitazone), which is marketed as Actos, Actoplus Met, and Duetact, has been linked with an increased risk of bladder cancer. Actos is manufactured and sold...